IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: An improved cardiomyocyte model to investigate inherited arrhythmia syndromes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 310, Issue 11, 2016, Pages H1611-H1621

  Vaidyanathan, Ravi ^a   Markandeya, Yogananda S ^a   Kamp, Timothy J ^a   Makielski, Jonathan C ^a   January, Craig T ^a   Eckhardt, Lee L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Arrhythmia; iPS CM; LQTS; Potassium ion channel

Indexed keywords

CALCIUM ION; CAVEOLIN 3; DNA; INWARDLY RECTIFYING POTASSIUM CHANNEL; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1;

ARTICLE; CALCIUM METABOLISM; CARDIAC MUSCLE CELL; CELL SIZE; CONTROLLED STUDY; DISEASE MODEL; DNA SYNTHESIS; ELECTROPHYSIOLOGY; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; HEART ARRHYTHMIA; HEART BEAT; HEART MUSCLE POTENTIAL; HEART PACING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELL; LONG QT SYNDROME; MEMBRANE STEADY POTENTIAL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM CURRENT; ACTION POTENTIAL; CYTOLOGY; MEMBRANE POTENTIAL; PHYSIOLOGY;

ACTION POTENTIALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC;

EID: 84983802068     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00481.2015     Document Type: Article

References (34)

1. Adsit GS, Vaidyanathan R, Galler CM, Kyle JW, Makielski JC. Channelopathies from mutations in the cardiac sodium channel protein complex. J Mol Cell Cardiol 61: 34–43, 2013.
2. Bett GC, Kaplan AD, Lis A, Cimato TR, Tzanakakis ES, Zhou Q, Morales MJ, Rasmusson RL. Electronic “expression” of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm 10: 1903–1910, 2013.
3. Cheng J, Valdivia CR, Vaidyanathan R, Balijepalli RC, Ackerman MJ, Makielski JC. Caveolin-3 suppresses late sodium current by inhib-iting nNOS-dependent S-nitrosylation of SCN5A. J Mol Cell Cardiol 61: 102–110, 2013.
4. Cohen CJ, Fozzard HA, Sheu SS. Increase in intracellular sodium ion activity during stimulation in mammalian cardiac muscle. Circ Res 50: 651–662, 1982.
5. Doss MX, Di Diego JM, Goodrow RJ, Wu Y, Cordeiro JM, Nest-erenko VV, Barajas-Martinez H, Hu D, Urrutia J, Desai M, Treat JA, Sachinidis A, Antzelevitch C. Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on I(Kr). PLoS One 7: e40288, 2012.
6. Harrell MD, Harbi S, Hoffman JF, Zavadil J, Coetzee WA. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. Physiol Genomics 28: 273–283, 2007.
7. Hill JA, Olson EN, Griendling KK. Muscle Fundamental Biology and Mechanisms of Disease (1st ed.) (Online). Waltham, MA: Academic, 2012.
8. Iglesias-Garcia O, Pelacho B, Prosper F. Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. J Mol Cell Cardiol 62: 43–50, 2013.
9. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gep-stein L. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471: 225–229, 2011.
10. Konig S, Beguet A, Bader CR, Bernheim L. The calcineurin pathway links hyperpolarization (Kir2.1)-induced Ca 2+ signals to human myoblast differentiation and fusion. Development 133: 3107–3114, 2006.
11. Konig S, Hinard V, Arnaudeau S, Holzer N, Potter G, Bader CR, Bernheim L. Membrane hyperpolarization triggers myogenin and myo-cyte enhancer factor-2 expression during human myoblast differentiation. J Biol Chem 279: 28187–28196, 2004.
12. Koumi S, Backer CL, Arentzen CE, Sato R. beta-Adrenergic modula-tion of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts. J Clin Invest 96: 2870–2881, 1995.
13. 2+ activity with stimulation in sheep cardiac Purkinje strands. Am J Physiol Heart Circ Physiol 243: H133–H137, 1982.
14. Lathrop DA, Varro A, Nanasi PP, Bodi II, Takyi E, Pankucsi C. Differences in the effects of d-and dl-sotalol on isolated human ventric-ular muscle: electromechanical activity after beta-adrenoceptor stimula-tion. J Cardiovasc Pharmacol Ther 1: 65–74, 1996.
15. Li GR, Feng J, Yue L, Carrier M. Transmural heterogeneity of action potentials and I to1 in myocytes isolated from the human right ventricle. Am J Physiol Heart Circ Physiol 275: H369–H377, 1998.
16. Li GR, Nattel S. Properties of human atrial I Ca at physiological temper-atures and relevance to action potential. Am J Physiol Heart Circ Physiol 272: H227–H235, 1997.
17. Lieu DK, Fu JD, Chiamvimonvat N, Tung KC, McNerney GP, Huser T, Keller G, Kong CW, Li RA. Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol 6: 191–201, 2013.
18. Ma J, Guo L, Fiene SJ, Anson BD, Thomson JA, Kamp TJ, Kolaja KL, Swanson BJ, January CT. High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of ac-tion potentials and ionic currents. Am J Physiol Heart Circ Physiol 301: H2006–H2017, 2011.
19. Milstein ML, Musa H, Balbuena DP, Anumonwo JM, Auerbach DS, Furspan PB, Hou L, Hu B, Schumacher SM, Vaidyanathan R, Mar-tens JR, Jalife J. Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmia. Proc Natl Acad Sci USA 109: E2134–2143, 2012.
20. Mollova M, Bersell K, Walsh S, Savla J, Das LT, Park SY, Silberstein LE, Dos Remedios CG, Graham D, Colan S, Kuhn B. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci USA 110: 1446–1451, 2013.
21. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Hohnke C, Hofmann F, Seyfarth M, Sinnecker D, Schomig A, Laugwitz KL. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 363: 1397–1409, 2010.
22. Nabauer M, Beuckelmann DJ, Uberfuhr P, Steinbeck G. Regional differences in current density and rate-dependent properties of the tran-sient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 93: 168–177, 1996.
23. Priori SG, Napolitano C, Di Pasquale E, Condorelli G. Induced pluripotent stem cell-derived cardiomyocytes in studies of inherited ar-rhythmias. J Clin Invest 123: 84–91, 2013.
24. Ruzsnavszky F, Hegyi B, Kistamas K, Vaczi K, Horvath B, Szentan-drassy N, Banyasz T, Nanasi PP, Magyar J. Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 387: 457–467, 2014.
25. Sanguinetti MC, Mitcheson JS. Predicting drug-hERG channel interac-tions that cause acquired long QT syndrome. Trends Pharmacol Sci 26: 119–124, 2005.
26. Ueda K, Valdivia C, Medeiros-Domingo A, Tester DJ, Vatta M, Farrugia G, Ackerman MJ, Makielski JC. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc Natl Acad Sci USA 105: 9355–9360, 2008.
27. Urrego D, Tomczak AP, Zahed F, Stuhmer W, Pardo LA. Potassium channels in cell cycle and cell proliferation. Philos Trans R Soc Lond B Biol Sci 369: 20130094, 2014.
28. Vaidyanathan R, Vega AL, Song C, Zhou Q, Tan B, Berger S, Makielski JC, Eckhardt LL. The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long QT syndrome 9 (LQT9). J Biol Chem 288: 17472–17480, 2013.
29. Valdivia CR, Ackerman MJ, Tester DJ, Wada T, McCormack J, Ye B, Makielski JC. A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine. Cardiovasc Res 55: 279–289, 2002.
30. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, Balijepalli RC, Foell JD, Li Z, Kamp TJ, Towbin JA. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114: 2104–2112, 2006.
31. Yazawa M, Dolmetsch RE. Modeling Timothy syndrome with iPS cells. J Cardiovasc Transl Res 6: 1–9, 2013.
32. Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz TL. Targeted disruption of Kir2.1 and Kir22 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation. Circ Res 87: 160–166, 2000.
33. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104: e30–41, 2009.
34. 2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and cat-echolaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects. Cell Calcium 54: 57–70, 2013.